The ALT-to-AST ratio (ALT/AST) showed a positive correlation in lung cancer and Hodgkin lymphoma but a negative correlation in breast cancer and non-Hodgkin lymphoma. This evidence concerns the gene GOT1 and non-Hodgkin lymphoma.